Harry Herr

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Herr Harry W
Editorial comment.
Herr Harry W
Editorial comment. Pelvic lymphadenectomy during robot-assisted radical prostatectomy: assessing nodal yield, perioperative outcomes, and complications.
Herr Harry W
Civiale, stones and statistics: the dawn of evidence-based medicine.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Harry Herr (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Herr Harry W
Editorial comment.
Urology 2009;74(4):864-5; author reply 865.
2009: Herr Harry W
Editorial comment. Pelvic lymphadenectomy during robot-assisted radical prostatectomy: assessing nodal yield, perioperative outcomes, and complications.
Urology 2009;74(2):302-3.
2009: Herr Harry W
Civiale, stones and statistics: the dawn of evidence-based medicine.
BJU international 2009;104(3):300-2.
2009: Herr Harry W
Editorial comment.
Urology 2009;74(1):166.
2009: Herr Harry W
'Cello scrotum' hoax.
BJU international 2009;103(11):1585.
2009: Herr Harry W
Editorial comment. Patients with low-grade papillary bladder tumors could be monitored safely, deferring therapy unless the recurrent tumors increased in size or number.
Urology 2009;73(6):1310-1.
2009: Gopalan Anuradha; Sharp David S; Fine Samson W; Tickoo Satish K; Herr Harry W; Reuter Victor E; Olgac Semra
Urachal carcinoma: a clinicopathologic analysis of 24 cases with outcome correlation.
The American journal of surgical pathology 2009;33(5):659-68.
2009: Herr Harry W
Editorial comment on: Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy.
European urology 2009;55(4):920-1.
2009: Ferra Susana; Denley Ryan; Herr Harry; Dalbagni Guido; Jhanwar Suresh; Lin Oscar
Reflex UroVysion testing in suspicious urine cytology cases.
Cancer cytopathology 2009;117(1):7-14.
2009: Montie James E; Clark Peter E; Eisenberger Mario A; El-Galley Rizk; Greenberg Richard E; Herr Harry W; Hudes Gary R; Kuban Deborah A; Kuzel Timothy M; Lange Paul H; Lele Subodh M; Michalski Jeffrey; Patterson Anthony; Pohar Kamal S; Richie Jerome P; Sexton Wade J; Shipley William U; Small Eric J; Trump Donald L; Walther Phillip J; Wilson Timothy G;
Bladder cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2009;7(1):8-39.
2009: Herr Harry; Konety Badrinath; Stein John; Sternberg Cora N; Wood David P
Optimizing outcomes at every stage of bladder cancer: do we practice it?
Urologic oncology 2009;27(1):72-4.
2009: Kurta Jordan M; Thompson R Houston; Kundu Shilajit; Kaag Matthew; Manion M Thomas; Herr Harry W; Russo Paul
Contemporary imaging of patients with a renal mass: does size on computed tomography equal pathological size?
BJU international 2009;103(1):24-7.
2008: Herr Harry W; Donat S Machele
Quality control in transurethral resection of bladder tumours.
BJU international 2008;102(9 Pt B):1242-6.
2008: Herr Harry W
Surgical management of renal tumors: a historical perspective.
The Urologic clinics of North America 2008;35(4):543-9; v.
2008: Sharma Padmanee; Bajorin Dean F; Jungbluth Achim A; Herr Harry; Old Lloyd J; Gnjatic Sacha
Immune responses detected in urothelial carcinoma patients after vaccination with NY-ESO-1 protein plus BCG and GM-CSF.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2008;31(9):849-57.
2008: Dash Atreya; Pettus Joseph A; Herr Harry W; Bochner Bernard H; Dalbagni Guido; Donat S Machele; Russo Paul; Boyle Mary G; Milowsky Matthew I; Bajorin Dean F
A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: a retrospective experience.
Cancer 2008;113(9):2471-7.
2008: Herr Harry W; Carver Brett
Point: effect of radiation-associated second malignancies on prostate cancer survival.
Urology 2008;72(5):968-70.
2008: Herr Harry W; Donat S Machele
A comparison of white-light cystoscopy and narrow-band imaging cystoscopy to detect bladder tumour recurrences.
BJU international 2008;102(9):1111-4.
2008: Herr Harry W
Is maintenance Bacillus Calmette-Guérin really necessary?
European urology 2008;54(5):971-3.
2008: Herr Harry W
'I will not cut . . . ': the oath that defined urology.
BJU international 2008;102(7):769-71.
2008: Herr Harry W
Editorial comment on: robotic-assisted laparoscopic radical cystectomy with extracorporeal urinary diversion: initial experience.
European urology 2008;54(3):579.
2008: Herr Harry W
'Crushing the stone': a brief history of lithotripsy, the first minimally invasive surgery.
BJU international 2008;102(4):432-5.
2008: Herr Harry W
Rebuttal from author re: Axel Heidenreich. Muscle-invasive urothelial carcinoma of the bladder: neoadjuvant chemotherapy enables organ preserving therapy in carefully selected patients. Eur Urol 2008;54:21-23.
European urology 2008;54(1):23-4.
2008: Herr Harry W
Outcome of patients who refuse cystectomy after receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer.
European urology 2008;54(1):126-32.
2008: Yossepowitch Ofer; Thompson R Houston; Leibovich Bradley C; Eggener Scott E; Pettus Joseph A; Kwon Eugene D; Herr Harry W; Blute Michael L; Russo Paul
Positive surgical margins at partial nephrectomy: predictors and oncological outcomes.
The Journal of urology 2008;179(6):2158-63.
2008: Koppie Theresa M; Serio Angel M; Vickers Andrew J; Vora Kinjal; Dalbagni Guido; Donat S Machele; Herr Harry W; Bochner Bernard H
Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer.
Cancer 2008;112(11):2384-92.
2008: Herr Harry W
'Cutting for the stone': the ancient art of lithotomy.
BJU international 2008;101(10):1214-6.
2008: Pettus Joseph A; Al-Ahmadie Hikmat; Barocas Daniel A; Koppie Theresa M; Herr Harry; Donat S Machele; Dalbagni Guido; Reuter Victor E; Olgac Semra; Bochner Bernard H
Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy.
European urology 2008;53(2):370-5.
2008: Kassouf Wassim; Agarwal Piyush K; Herr Harry W; Munsell Mark F; Spiess Philippe E; Brown Gordon A; Pisters Louis; Grossman H Barton; Dinney Colin P; Kamat Ashish M
Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(1):121-6.
2008: Herr Harry W
Is radical radiotherapy effective in patients with pT1G3 NXM0 bladder cancer?
Nature clinical practice. Urology 2008;5(1):22-3.
2008: Tran William; Serio Angel M; Raj Ganesh V; Dalbagni Guido; Vickers Andrew J; Bochner Bernard H; Herr Harry; Donat S Machele
Longitudinal risk of upper tract recurrence following radical cystectomy for urothelial cancer and the potential implications for long-term surveillance.
The Journal of urology 2008;179(1):96-100.
2008: Herr Harry W; Morales Alvaro
History of bacillus Calmette-Guerin and bladder cancer: an immunotherapy success story.
The Journal of urology 2008;179(1):53-6.
2008: Herr Harry W
Low risk bladder tumors--less is more!
The Journal of urology 2008;179(1):13-4.
2008: Herr Harry W
Re: Francesco Montorsi. A plea for integrating laparoscopy and robotic surgery in everyday urology: the rules of the game. Eur urol 2007;52:307-9.
European urology 2008;53(1):3-4; author reply 1.
2007: Dotan Zohar A; Kavanagh Kathryn; Yossepowitch Ofer; Kaag Matt; Olgac Semra; Donat Machele; Herr Harry W
Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
The Journal of urology 2007;178(6):2308-12; discussion 2313.
2007: Herr Harry W; Donat S Machele; Reuter Victor E
Management of low grade papillary bladder tumors.
The Journal of urology 2007;178(4 Pt 1):1201-5; discussion 1205.
2007: Herr Harry W
Age and outcome of superficial bladder cancer treated with bacille Calmette-Guérin therapy.
Urology 2007;70(1):65-8.
2007: Herr Harry W; Bochner Bernard H; Sharp David; Dalbagni Guido; Reuter Victor E
Urachal carcinoma: contemporary surgical outcomes.
The Journal of urology 2007;178(1):74-8; discussion 78.
2007: Nieder Alan M; Soloway Mark S; Herr Harry W
Should we abandon the FISH test?
European urology 2007;51(6):1469-71.
2007: Herr Harry W
Does difluoromethylornithine prevent recurrence in low-risk superficial bladder cancer?
Nature clinical practice. Urology 2007;4(5):240-1.
2007: Raj Ganesh V; Herr Harry; Serio Angel M; Donat Sherri M; Bochner Bernard H; Vickers Andrew J; Dalbagni Guido
Treatment paradigm shift may improve survival of patients with high risk superficial bladder cancer.
The Journal of urology 2007;177(4):1283-6; discussion 1286.
2007: Yossepowitch Ofer; Herr Harry W; Donat S Machele
Use of urinary biomarkers for bladder cancer surveillance: patient perspectives.
The Journal of urology 2007;177(4):1277-82; discussion 1282.
2007: Herr Harry W
The concept of lymph node density--is it ready for clinical practice?
The Journal of urology 2007;177(4):1273-5; discussion 1275-6.
2007: Herr Harry W
Hunter Holmes McGuire and the coffee pot spout procedure.
The Journal of urology 2007;177(4):1250-3.
2007: Sharma Padmanee; Shen Yu; Wen Sijin; Yamada Sachiko; Jungbluth Achim A; Gnjatic Sacha; Bajorin Dean F; Reuter Victor E; Herr Harry; Old Lloyd J; Sato Eiichi
CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(10):3967-72.
2007: Galsky Matthew D; Iasonos Alexia; Mironov Svetlana; Scattergood Joseph; Donat S Machele; Bochner Bernard H; Herr Harry W; Russo Paul; Boyle Mary G; Bajorin Dean F
Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract.
Urology 2007;69(2):255-9.
2007: Herr Harry W
Ignorance is bliss: the Listerian revolution and education of American surgeons.
The Journal of urology 2007;177(2):457-60.
2007: Herr Harry W; Dotan Zohar; Donat S Machele; Bajorin Dean F
Defining optimal therapy for muscle invasive bladder cancer.
The Journal of urology 2007;177(2):437-43.
2007: Dalbagni Guido; Parekh Dipen J; Ben-Porat Leah; Potenzoni Michele; Herr Harry W; Reuter Victor E
Prospective evaluation of p53 as a prognostic marker in T1 transitional cell carcinoma of the bladder.
BJU international 2007;99(2):281-5.
2007: Herr Harry W; Donat S Machele; Dalbagni Guido
Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy?
The Journal of urology 2007;177(1):75-9; discussion 79.
2006: Montie James E; Abrahams Neil A; Bahnson Robert R; Eisenberger Mario A; El-Galley Rizk; Herr Harry W; Hudes Gary R; Kuzel Timothy M; Lange Paul H; Patterson Anthony; Pollack Alan; Richie Jerome P; Sexton Wade J; Shipley William U; Small Eric J; Trump Donald L; Walther Phillip J; Wilson Timothy G;
Bladder cancer. Clinical guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4(10):984-1014.
2006: Raj Ganesh V; Bochner Bernard H; Serio Angel M; Vickers Andrew; Donat S Machele; Herr Harry; Lin Oscar; Dalbagni Guido
Natural history of positive urinary cytology after radical cystectomy.
The Journal of urology 2006;176(5):2000-5; discussion 2005.
2006: Herr Harry W
The enlarged prostate: a brief history of its surgical treatment.
BJU international 2006;98(5):947-52.
2006: Raj Ganesh V; Tal Raanan; Vickers Andrew; Bochner Bernard H; Serio Angel; Donat S Machele; Herr Harry; Olgac Semra; Dalbagni Guido
Significance of intraoperative ureteral evaluation at radical cystectomy for urothelial cancer.
Cancer 2006;107(9):2167-72.
2006: Maluf F C; Cordon-Cardo C; Verbel D A; Satagopan J M; Boyle M G; Herr H; Bajorin D F
Assessing interactions between mdm-2, p53, and bcl-2 as prognostic variables in muscle-invasive bladder cancer treated with neo-adjuvant chemotherapy followed by locoregional surgical treatment.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(11):1677-86.
2006: Herr Harry W
Max Nitze, the cystoscope and urology.
The Journal of urology 2006;176(4 Pt 1):1313-6.
2006: Herr Harry W
Henry Wade (1876-1955): an early 20th century cancer researcher and pioneer urologist.
BJU international 2006;98(3):514-8.
2006: Yossepowitch Ofer; Eggener Scott E; Bochner Bernard H; Donat S Machele; Herr Harry W; Dalbagni Guido
Safety and efficacy of intravesical bacillus Calmette-Guerin instillations in steroid treated and immunocompromised patients.
The Journal of urology 2006;176(2):482-5.
2006: Eggener Scott; Herr Harry
NMP22 and surveillance for recurrent bladder cancer.
JAMA : the journal of the American Medical Association 2006;296(1):45; author reply 45-6.
2006: Raj Ganesh V; Iasonos Alexia; Herr Harry; Donat Sherri Machele
Formulas calculating creatinine clearance are inadequate for determining eligibility for Cisplatin-based chemotherapy in bladder cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(19):3095-100.
2006: Konety Badrinath R; Allareddy Veerasathpurush; Herr Harry
Complications after radical cystectomy: analysis of population-based data.
Urology 2006;68(1):58-64.
2006: Sandhu Jaspreet S; Vickers Andrew J; Bochner Bernard; Donat S Machele; Herr Harry W; Dalbagni Guido
Clinical characteristics of bladder cancer in patients previously treated with radiation for prostate cancer.
BJU international 2006;98(1):59-62.
2006: Dalbagni Guido; Russo Paul; Bochner Bernard; Ben-Porat Leah; Sheinfeld Joel; Sogani Pramod; Donat Machelle S; Herr Harry W; Bajorin Dean
Phase II trial of intravesical gemcitabine in bacille Calmette-Guérin-refractory transitional cell carcinoma of the bladder.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(18):2729-34.
2006: Raj Ganesh V; Bochner Bernard H; Vickers Andrew; Teper Ervin; Lin Oscar; Donat S Machele; Herr Harry; Dalbagni Guido
Association between urinary cytology and pathology for nontransitional cell malignancies of the urinary tract.
The Journal of urology 2006;175(6):2038-41; discussion 2041.
2006: Herr Harry W; Donat S Machele
A re-staging transurethral resection predicts early progression of superficial bladder cancer.
BJU international 2006;97(6):1194-8.
2006: Herr Harry W
Early history of endoscopic treatment of bladder tumors from Grunfeld's polypenkneipe to the Stern-McCarthy resectoscope.
Journal of endourology / Endourological Society 2006;20(2):85-91.
2005: Herr Harry W
Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy.
The Journal of urology 2005;174(6):2134-7.
2005: Herr Harry W; Regan Marisa
Urine cytology after flexible cystoscopy.
BJU international 2005;96(6):796-7.
2005: Herr Harry W
Franklin, Lavoisier, and Mesmer: origin of the controlled clinical trial.
Urologic oncology 2005;23(5):346-51.
2005: Schrag Deborah; Mitra Nandita; Xu Feng; Rabbani Farhang; Bach Peter B; Herr Harry; Begg Colin B
Cystectomy for muscle-invasive bladder cancer: patterns and outcomes of care in the Medicare population.
Urology 2005;65(6):1118-25.
2005: Herr Harry W
Surgical factors in the treatment of superficial and invasive bladder cancer.
The Urologic clinics of North America 2005;32(2):157-64.
2005: Hafron Jason; Mitra Nandita; Dalbagni Guido; Bochner Bernard; Herr Harry; Donat S Machele
Does body mass index affect survival of patients undergoing radical or partial cystectomy for bladder cancer?
The Journal of urology 2005;173(5):1513-7.
2005: Herr Harry W; McAninch Jack W
Urethral injuries in the Civil War.
The Journal of urology 2005;173(4):1090-3.
2005: Herr Harry W
Legacy of Edwin Beer: fulguration of papillary bladder tumors.
The Journal of urology 2005;173(4):1087-9.
2005: Herr Harry W
Is less radical cystectomy better, and how can we be sure?
The Journal of urology 2005;173(4):1063.
2005: Herr Harry W
A history of partial nephrectomy for renal tumors.
The Journal of urology 2005;173(3):705-8.
2005: Galsky Matthew D; Herr Harry W; Bajorin Dean E
The integration of chemotherapy and surgery for bladder cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2005;3(1):45-51.
2005: Montie James E; Bahnson Robert R; Cohen Samuel M; Drucker Beverly; Eisenberger Mario A; El-Galley Rizk; Herr Harry W; Hudes Gary R; Kuzel Timothy M; Lange Paul H; Patterson Anthony; Pollack Alan; Richie Jerome P; Seigne John; Shipley William U; Small Eric J; Trump Donald L; Walther Philip J; Wilson Timothy G
Bladder cancer. Clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2005;3(1):4-5, 19-34.
2004: Mullerad Michael; Russo Paul; Golijanin Dragan; Chen Hui Ni; Tsai Harold H; Donat S Machele; Bochner Bernard H; Herr Harry W; Sheinfeld Joel; Sogani Pramod C; Kattan Michael W; Dalbagni Guido
Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma.
The Journal of urology 2004;172(6 Pt 1):2177-81.
2004: Herr Harry W
Urological injuries in the Civil War.
The Journal of urology 2004;172(5 Pt 1):1800-4.
2004: Bochner Bernard H; Cho Daniel; Herr Harry W; Donat Machele; Kattan Michael W; Dalbagni Guido
Prospectively packaged lymph node dissections with radical cystectomy: evaluation of node count variability and node mapping.
The Journal of urology 2004;172(4 Pt 1):1286-90.
2004: Herr Harry W; Smith Joseph A; Montie James E
Standardization of radical cystectomy: time to count and be counted.
BJU international 2004;94(4):481-2.
2004: Holzbeierlein Jeffrey M; Lopez-Corona Ernesto; Bochner Bernard H; Herr Harry W; Donat S Machele; Russo Paul; Dalbagni Guido; Sogani Pramod C
Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection.
The Journal of urology 2004;172(3):878-81.
2004: Herr Harry W; Faulkner James R; Grossman H Barton; Natale Ronald B; deVere White Ralph; Sarosdy Michael F; Crawford E David
Surgical factors influence bladder cancer outcomes: a cooperative group report.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(14):2781-9.
2004: Herr Harry W; Faulkner James R; Grossman H Barton; Crawford E David
Pathologic evaluation of radical cystectomy specimens: a cooperative group report.
Cancer 2004;100(11):2470-5.
2004: Herr Harry; Lee Cheryl; Chang Sam; Lerner Seth;
Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: a collaborative group report.
The Journal of urology 2004;171(5):1823-8; discussion 1827-8.
2004: Konety Badrinath R; Eastham James A; Reuter Vicor E; Scardino Peter T; Donat S Machele; Dalbagni Guido; Russo Paul; Herr Harry W; Schwartz Larry; Kantoff Philip W; Scher Howard; Kelly W Kevin
Feasibility of radical prostatectomy after neoadjuvant chemohormonal therapy for patients with high risk or locally advanced prostate cancer: results of a phase I/II study.
The Journal of urology 2004;171(2 Pt 1):709-13.
2004: Donat S Machele; North Amanda; Dalbagni Guido; Herr Harry W
Efficacy of office fulguration for recurrent low grade papillary bladder tumors less than 0.5 cm.
The Journal of urology 2004;171(2 Pt 1):636-9.
2003: Sharma Padmanee; Gnjatic Sacha; Jungbluth Achim A; Williamson Barbara; Herr Harry; Stockert Elisabeth; Dalbagni Guido; Donat S Machele; Reuter Victor E; Santiago Darren; Chen Yao-Tseng; Bajorin Dean F; Old Lloyd J
Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer.
Cancer immunity : a journal of the Academy of Cancer Immunology 2003;3():19.
2003: Donat S Machele; Bayuga Sharon; Herr Harry W; Berwick Marianne
Fluid intake and the risk of tumor recurrence in patients with superficial bladder cancer.
The Journal of urology 2003;170(5):1777-80.
2003: Andonian Sero; Karakiewicz Pierre I; Herr Harry W
Presacral cystic schwannoma in a man.
Urology 2003;62(3):551.
2003: Herr H W
Surgical factors in bladder cancer: more (nodes) + more (pathology) = less (mortality).
BJU international 2003;92(3):187-8.
2003: Herr Harry W; Dalbagni Guido
Defining bacillus Calmette-Guerin refractory superficial bladder tumors.
The Journal of urology 2003;169(5):1706-8.
2003: Schrag Deborah; Hsieh Lillian J; Rabbani Farhang; Bach Peter B; Herr Harry; Begg Colin B
Adherence to surveillance among patients with superficial bladder cancer.
Journal of the National Cancer Institute 2003;95(8):588-97.
2003: Lin Daniel W; Herr Harry W; Dalbagni Guido
Value of urethral wash cytology in the retained male urethra after radical cystoprostatectomy.
The Journal of urology 2003;169(3):961-3.
2003: Herr Harry W
Superiority of ratio based lymph node staging for bladder cancer.
The Journal of urology 2003;169(3):943-5.
2003: Herr Harry W
Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomy.
Urology 2003;61(1):105-8.
2003: Yossepowitch Ofer; Dalbagni Guido; Golijanin Dragan; Donat S Machele; Bochner Bernard H; Herr Harry W; Fair William R; Russo Paul
Orthotopic urinary diversion after cystectomy for bladder cancer: implications for cancer control and patterns of disease recurrence.
The Journal of urology 2003;169(1):177-81.
2002: Herr Harry W
Reply to editorial -- Technologies and traditional skills, Laurence H. Klotz, Can J Urol 2002;9(4):1572-1573.
The Canadian journal of urology 2002;9(6):1707.
2002: Dalbagni Guido; Herr Harry W; Reuter Victor E
Impact of a second transurethral resection on the staging of T1 bladder cancer.
Urology 2002;60(5):822-4; discussion 824-5.
2002: Herr Harry W; Donat S Machele; Dalbagni Guido
Correlation of cystoscopy with histology of recurrent papillary tumors of the bladder.
The Journal of urology 2002;168(3):978-80.
2002: Herr Harry W
Pathologic evaluation of radical cystectomy specimens.
Cancer 2002;95(3):668-9.
2002: Dalbagni Guido; Russo Paul; Sheinfeld Joel; Mazumdar Madhu; Tong William; Rabbani Farhang; Donat Machelle S; Herr Harry W; Sogani Pramod; dePalma Dominique; Bajorin Dean
Phase I trial of intravesical gemcitabine in bacillus Calmette-Guérin-refractory transitional-cell carcinoma of the bladder.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(15):3193-8.
2002: Rabbani Farhang; Herr Harry W; Almahmeed Taghreed; Russo Paul
Temporal change in risk of metachronous contralateral renal cell carcinoma: influence of tumor characteristics and demographic factors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(9):2370-5.
2002: Herr Harry W; Bochner Bernard H; Dalbagni Guido; Donat S Machele; Reuter Victor E; Bajorin Dean F
Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer.
The Journal of urology 2002;167(3):1295-8.
2002: McKiernan J M; Teschendorf B; Katz J; Herr H W; Russo P
A comparison of hospital-based charges following partial and radical nephrectomy.
Urologic oncology 2002;7(1):3-6.
2001: Herr H W; Schneider M
Immediate versus delayed outpatient flexible cystoscopy: final report of a randomized study.
The Canadian journal of urology 2001;8(6):1406-8.
2001: Bochner B H; Herr H W; Reuter V E
Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens.
The Journal of urology 2001;166(6):2295-6.
2001: Herr H W
Does cystoscopy correlate with the histology of recurrent papillary tumours of the bladder?
BJU international 2001;88(7):683-5.
2001: Dalbagni G; Donat S M; Eschwège P; Herr H W; Zelefsky M J
Results of high dose rate brachytherapy, anterior pelvic exenteration and external beam radiotherapy for carcinoma of the female urethra.
The Journal of urology 2001;166(5):1759-61.
2001: Herr H W; Sogani P C
Does early cystectomy improve the survival of patients with high risk superficial bladder tumors?
The Journal of urology 2001;166(4):1296-9.
2001: Dalbagni G; Ren Z P; Herr H; Cordon-Cardo C; Reuter V
Genetic alterations in tp53 in recurrent urothelial cancer: a longitudinal study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(9):2797-801.
2001: Herr H W; Lee C T; Sharma S; Hilton S
Radiographic versus pathologic size of renal tumors: implications for partial nephrectomy.
Urology 2001;58(2):157-60.
2001: Herr H W; Schneider M
Outpatient flexible cystoscopy in men: a randomized study of patient tolerance.
The Journal of urology 2001;165(6 Pt 1):1971-2.
2001: Donat S M; Wei D C; McGuire M S; Herr H W
The efficacy of transurethral biopsy for predicting the long-term clinical impact of prostatic invasive bladder cancer.
The Journal of urology 2001;165(5):1580-4.
2001: Rabbani F; Sheinfeld J; Farivar-Mohseni H; Leon A; Rentzepis M J; Reuter V E; Herr H W; McCaffrey J A; Motzer R J; Bajorin D F; Bosl G J
Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: pattern and prognostic factors for relapse.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(7):2020-5.
2001: Donat S M; Genega E M; Herr H W; Reuter V E
Mechanisms of prostatic stromal invasion in patients with bladder cancer: clinical significance.
The Journal of urology 2001;165(4):1117-20.
2001: Dalbagni G; Genega E; Hashibe M; Zhang Z F; Russo P; Herr H; Reuter V
Cystectomy for bladder cancer: a contemporary series.
The Journal of urology 2001;165(4):1111-6.
2001: Herr H W; Donat S M; Bajorin D F
Post-chemotherapy surgery in patients with unresectable or regionally metastatic bladder cancer.
The Journal of urology 2001;165(3):811-4.
2001: Herr H W
Editorial comment.
Urology 2001;57(1):59.
2001: Rabbani F; Perrotti M; Russo P; Herr H W
Upper-tract tumors after an initial diagnosis of bladder cancer: argument for long-term surveillance.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(1):94-100.
2001: Herr H W
Transurethral resection of muscle-invasive bladder cancer: 10-year outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(1):89-93.
2001: Herr H W; Donat S M
Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy.
The Journal of urology 2001;165(1):62-4; discussion 64.
2000: Dodd P M; McCaffrey J A; Mazumdar M; Icasiano E; Higgins G; Herr H; Bajorin D F
Phase II trial of pyrazoloacridine as second-line therapy for patients with unresectable or metastatic transitional cell carcinoma.
Investigational new drugs 2000;18(3):247-51.
2000: Herr H W; O'Sullivan M
Quality of life of asymptomatic men with nonmetastatic prostate cancer on androgen deprivation therapy.
The Journal of urology 2000;163(6):1743-6.
2000: Bajorin D F; McCaffrey J A; Dodd P M; Hilton S; Mazumdar M; Kelly W K; Herr H; Scher H I; Icasiano E; Higgins G
Ifosfamide, paclitaxel, and cisplatin for patients with advanced transitional cell carcinoma of the urothelial tract: final report of a phase II trial evaluating two dosing schedules.
Cancer 2000;88(7):1671-8.
2000: Dalbagni G; Herr H W
Current use and questions concerning intravesical bladder cancer group for superficial bladder cancer.
The Urologic clinics of North America 2000;27(1):137-46,.
2000: Dodd P M; McCaffrey J A; Hilton S; Mazumdar M; Herr H; Kelly W K; Icasiano E; Boyle M G; Bajorin D F
Phase I evaluation of sequential doxorubicin gemcitabine then ifosfamide paclitaxel cisplatin for patients with unresectable or metastatic transitional-cell carcinoma of the urothelial tract.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(4):840-6.
2000: Herr H W
Radiographic vs surgical size of renal tumours after partial nephrectomy.
BJU international 2000;85(1):19-21.
2000: Herr H W
Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors: 15-year outcome.
The Journal of urology 2000;163(1):60-1; discussion 61-2.
2000: Rørth M; Rajpert-De Meyts E; Andersson L; Dieckmann K P; Fosså S D; Grigor K M; Hendry W F; Herr H W; Looijenga L H; Oosterhuis J W; Skakkebaek N E
Carcinoma in situ in the testis.
Scandinavian journal of urology and nephrology. Supplementum 2000;(205):166-86.
2000: Dodd P M; McCaffrey J A; Mazumdar M; Scher H; Higgins G; Boyle M G; Herr H; Bajorin D F
Evaluation of drug delivery and survival impact of dose-intense relative to conventional-dose methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy in urothelial cancer.
Cancer investigation 2000;18(7):626-34.
1999: Fleshner N; Garland J; Moadel A; Herr H; Ostroff J; Trambert R; O'Sullivan M; Russo P
Influence of smoking status on the disease-related outcomes of patients with tobacco-associated superficial transitional cell carcinoma of the bladder.
Cancer 1999;86(11):2337-45.
1999: Herr H W
The natural history of a T1 bladder cancer: life-long tumour diathesis.
BJU international 1999;84(9):1102-3.
1999: Bajorin D F; Dodd P M; Mazumdar M; Fazzari M; McCaffrey J A; Scher H I; Herr H; Higgins G; Boyle M G
Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(10):3173-81.
1999: Herr H W; Reuter V E
Progression of T1 bladder tumors: better staging or better biology?
Cancer 1999;86(6):908-12.
1999: Dalbagni G; Rechtschaffen T; Herr H W
Is transurethral biopsy of the bladder necessary after 3 months to evaluate response to bacillus Calmette-Guerin therapy?
The Journal of urology 1999;162(3 Pt 1):708-9.
1999: Dodd P M; McCaffrey J A; Herr H; Mazumdar M; Bacik J; Higgins G; Boyle M G; Scher H I; Bajorin D F
Outcome of postchemotherapy surgery after treatment with methotrexate, vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(8):2546-52.
1999: Herr H W
The value of a second transurethral resection in evaluating patients with bladder tumors.
The Journal of urology 1999;162(1):74-6.
1999: Dalbagni G; Zhang Z F; Lacombe L; Herr H W
Male urethral carcinoma: analysis of treatment outcome.
Urology 1999;53(6):1126-32.
1999: Herr H W; Donat S M
Prostatic tumor relapse in patients with superficial bladder tumors: 15-year outcome.
The Journal of urology 1999;161(6):1854-7.
1999: Dodd P M; McCaffrey J A; Mazumdar M; Scher H; Vlamis V; Higgins G; Herr H; Bajorin D F
Phase II trial of intermediate dose methotrexate in combination with vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma.
Cancer 1999;85(5):1145-50.
1999: Vieweg J; Gschwend J E; Herr H W; Fair W R
Pelvic lymph node dissection can be curative in patients with node positive bladder cancer.
The Journal of urology 1999;161(2):449-54.
1999: Vieweg J; Gschwend J E; Herr H W; Fair W R
The impact of primary stage on survival in patients with lymph node positive bladder cancer.
The Journal of urology 1999;161(1):72-6.
1999: Herr H W
Partial nephrectomy for unilateral renal carcinoma and a normal contralateral kidney: 10-year followup.
The Journal of urology 1999;161(1):33-4; discussion 34-5.
1999: Herr H W; Bajorin D F; Scher H I; Cordon-Cardo C; Reuter V E
Can p53 help select patients with invasive bladder cancer for bladder preservation?
The Journal of urology 1999;161(1):20-2; discussion 22-3.
1998: Dalbagni G; Zhang Z F; Lacombe L; Herr H W
Female urethral carcinoma: an analysis of treatment outcome and a plea for a standardized management strategy.
British journal of urology 1998;82(6):835-41.
1998: Bajorin D F; McCaffrey J A; Hilton S; Mazumdar M; Kelly W K; Scher H I; Spicer J; Herr H; Higgins G
Treatment of patients with transitional-cell carcinoma of the urothelial tract with ifosfamide, paclitaxel, and cisplatin: a phase II trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(8):2722-7.
1998: Scher H; Bahnson R; Cohen S; Eisenberger M; Herr H; Kozlowski J; Lange P; Montie J; Pollack A; Raghaven D; Richie J; Shipley W
NCCN urothelial cancer practice guidelines. National Comprehensive Cancer Network.
Oncology (Williston Park, N.Y.) 1998;12(7A):225-71.
1998: Herr H W; Reuter V E
Evaluation of new resectoscope loop for transurethral resection of bladder tumors.
The Journal of urology 1998;159(6):2067-8.
1998: Sheinfeld J; Herr H W
Role of surgery in management of germ cell tumor.
Seminars in oncology 1998;25(2):203-9.
1998: Herr H W; Bajorin D F; Scher H I
Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: ten-year outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(4):1298-301.
1998: Wolchok J D; Herr H W; Kelly W K
Localized squamous cell carcinoma of the bladder causing hypercalcemia and inhibition of PTH secretion.
Urology 1998;51(3):489-91.
1998: Herr H W
Extravesical tumor relapse in patients with superficial bladder tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(3):1099-102.
1998: Sogani P C; Perrotti M; Herr H W; Fair W R; Thaler H T; Bosl G
Clinical stage I testis cancer: long-term outcome of patients on surveillance.
The Journal of urology 1998;159(3):855-8.
1998: Herr H W; Bar-Chama N; O'Sullivan M; Sogani P C
Paternity in men with stage I testis tumors on surveillance.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(2):733-4.
1998: Herr H W
Prognostic risk factors in low stage testicular germ cell tumors: unanswered questions regarding clinically useful prognosticators for extratesticular disease.
Cancer 1998;82(1):230-2.
1997: Stroumbakis N; Herr H W; Cookson M S; Fair W R
Radical cystectomy in the octogenarian.
The Journal of urology 1997;158(6):2113-7.
1997: Herr H W
Tumour progression and survival in patients with T1G3 bladder tumours: 15-year outcome.
British journal of urology 1997;80(5):762-5.
1997: Herr H W
Does necrosis on frozen-section analysis of a mass after chemotherapy justify a limited retroperitoneal resection in patients with advanced testis cancer?
British journal of urology 1997;80(4):653-7.
1997: McCaffrey J A; Herr H W
Adjuvant and neoadjuvant chemotherapy for urothelial carcinoma.
Surgical oncology clinics of North America 1997;6(4):667-81.
1997: Herr H W; Sheinfeld J
Is biopsy of the contralateral testis necessary in patients with germ cell tumors?
The Journal of urology 1997;158(4):1331-4.
1997: Dalbagni G; Han W; Zhang Z F; Cordon-Cardo C; Saigo P; Fair W R; Herr H; Kim N; Moore M A
Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(9):1593-8.
1997: Silver D A; Stroumbakis N; Russo P; Fair W R; Herr H W
Ureteral carcinoma in situ at radical cystectomy: does the margin matter?
The Journal of urology 1997;158(3 Pt 1):768-71.
1997: Herr H W
High-risk superficial bladder cancer: transurethral resection alone in selected patients with T1 tumor.
Seminars in urologic oncology 1997;15(3):142-6.
1997: Hilton S; Herr H W; Teitcher J B; Begg C B; Castéllino R A
CT detection of retroperitoneal lymph node metastases in patients with clinical stage I testicular nonseminomatous germ cell cancer: assessment of size and distribution criteria.
AJR. American journal of roentgenology 1997;169(2):521-5.
1997: Herr H W
Quality of life in prostate cancer patients.
CA: a cancer journal for clinicians 1997;47(4):207-17.
1997: Cookson M S; Herr H W; Zhang Z F; Soloway S; Sogani P C; Fair W R
The treated natural history of high risk superficial bladder cancer: 15-year outcome.
The Journal of urology 1997;158(1):62-7.
1997: Herr H W; Fradet Y; Klein F A
Summary of effect of intravesical bacillus Calmette-Guerin (BCG) on carcinoma in situ of the bladder (by Harry W. Herr, MD, Carl M. Pinsky, MD, Willet F. Whitmore, Jr, MD, Herbert F. Oettgen, MD, and Myron R. Melamed, MD). 1983.
Seminars in urologic oncology 1997;15(2):80-5.
1997: Fair W R; Cookson M S; Stroumbakis N; Cohen D; Aprikian A G; Wang Y; Russo P; Soloway S M; Sogani P; Sheinfeld J; Herr H; Dalgabni G; Begg C B; Heston W D; Reuter V E
The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center results.
Urology 1997;49(3A Suppl):46-55.
1997: Herr H W
Does current chemotherapy improve survival of patients with invasive bladder cancer?
Urology 1997;49(3):309-12.
1997: Cookson M S; Sogani P C; Russo P; Sheinfeld J; Herr H; Dalbagni G; Reuter V E; Begg C B; Fair W R
Pathological staging and biochemical recurrence after neoadjuvant androgen deprivation therapy in combination with radical prostatectomy in clinically localized prostate cancer: results of a phase II study.
British journal of urology 1997;79(3):432-8.
1997: Herr H W; Sheinfeld J; Puc H S; Heelan R; Bajorin D F; Mencel P; Bosl G J; Motzer R J
Surgery for a post-chemotherapy residual mass in seminoma.
The Journal of urology 1997;157(3):860-2.
1997: Herr H W
Natural history of superficial bladder tumors: 10- to 20-year follow-up of treated patients.
World journal of urology 1997;15(2):84-8.
1996: Lacombe L; Dalbagni G; Zhang Z F; Cordon-Cardo C; Fair W R; Herr H W; Reuter V E
Overexpression of p53 protein in a high-risk population of patients with superficial bladder cancer before and after bacillus Calmette-Guérin therapy: correlation to clinical outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(10):2646-52.
1996: Fleshner N E; Herr H W; Stewart A K; Murphy G P; Mettlin C; Menck H R
The National Cancer Data Base report on bladder carcinoma. The American College of Surgeons Commission on Cancer and the American Cancer Society.
Cancer 1996;78(7):1505-13.
1996: Herr H W; Cookson M S; Soloway S M
Upper tract tumors in patients with primary bladder cancer followed for 15 years.
The Journal of urology 1996;156(4):1286-7.
1996: Donat S M; Herr H W; Bajorin D F; Fair W R; Sogani P C; Russo P; Sheinfeld J; Scher I
Methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy and cystectomy for unresectable bladder cancer.
The Journal of urology 1996;156(2 Pt 1):368-71.
1996: Brenner P C; Herr H W; Morse M J; Sheinfeld J; Aprikian A; Bosl G J; Motzer R J; Bajorin D F; Schantz S; Fair W R; Burt M
Simultaneous retroperitoneal, thoracic, and cervical resection of postchemotherapy residual masses in patients with metastatic nonseminomatous germ cell tumors of the testis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(6):1765-9.
1996: Herr H W
Routine CT scan in cystectomy patients: does it change management?
Urology 1996;47(3):324-5.
1996: Motzer R J; Sheinfeld J; Herr H
Defining new standards for adjuvant therapy of testis cancer: a reply.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):680.
1996: Puc H S; Heelan R; Mazumdar M; Herr H; Scheinfeld J; Vlamis V; Bajorin D F; Bosl G J; Mencel P; Motzer R J
Management of residual mass in advanced seminoma: results and recommendations from the Memorial Sloan-Kettering Cancer Center.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):454-60.
1996: Aronson D C; Medary I; Finlay J L; Herr H W; Exelby P R; La Quaglia M P
Renal cell carcinoma in childhood and adolescence: a retrospective survey for prognostic factors in 22 cases.
Journal of pediatric surgery 1996;31(1):183-6.
1995: Motzer R J; Sheinfeld J; Mazumdar M; Bajorin D F; Bosl G J; Herr H; Lyn P; Vlamis V
Etoposide and cisplatin adjuvant therapy for patients with pathologic stage II germ cell tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(11):2700-4.
1995: Begg C B; Zhang Z F; Sun M; Herr H W; Schantz S P
Methodology for evaluating the incidence of second primary cancers with application to smoking-related cancers from the Surveillance, Epidemiology, and End Results (SEER) program.
American journal of epidemiology 1995;142(6):653-65.
1995: Herr H W; Schwalb D M; Zhang Z F; Sogani P C; Fair W R; Whitmore W F; Oettgen H F
Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(6):1404-8.
1995: Sarkis A S; Bajorin D F; Reuter V E; Herr H W; Netto G; Zhang Z F; Schultz P K; Cordon-Cardo C; Scher H I
Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(6):1384-90.
1995: Kurth K H; Schellhammer P F; Okajima E; Akdas A; Jakse G; Herr H W; Calais da Silva F; Fukushima S; Nagayama T
Current methods of assessing and treating carcinoma in situ of the bladder with or without involvement of the prostatic urethra.
International journal of urology : official journal of the Japanese Urological Association 1995;2 Suppl 2():8-22.
1995: Sternberg C N; Raghaven D; Ohi Y; Bajorin D; Herr H; Kato T; Kuroda M; Logothetis C H; Scher H; Splinter T A
Neoadjuvant and adjuvant chemotherapy in advanced disease--what are the effects on survival and prognosis?
International journal of urology : official journal of the Japanese Urological Association 1995;2 Suppl 2():76-88.
1995: Jones G W; Mettlin C; Murphy G P; Guinan P; Herr H W; Hussey D H; Chmiel J S; Fremgen A M; Clive R E; Zuber-Ocwieja K E
Patterns of care for carcinoma of the prostate gland: results of a national survey of 1984 and 1990.
Journal of the American College of Surgeons 1995;180(5):545-54.
1995: Hudson M A; Herr H W
Carcinoma in situ of the bladder.
The Journal of urology 1995;153(3 Pt 1):564-72.
1994: Aprikian A G; Fair W R; Reuter V E; Sogani P; Herr H; Russo P; Sheinfeld J
Experience with neoadjuvant diethylstilboestrol and radical prostatectomy in patients with locally advanced prostate cancer.
British journal of urology 1994;74(5):630-6.
1994: Herr H W
Partial nephrectomy for incidental renal cell carcinoma.
British journal of urology 1994;74(4):431-3.
1994: Aprikian A G; Herr H W; Bajorin D F; Bosl G J
Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors.
Cancer 1994;74(4):1329-34.
1994: Herr H W
Uncertainty, stage and outcome of invasive bladder cancer.
The Journal of urology 1994;152(2 Pt 1):401-2.
1994: Sarkis A S; Dalbagni G; Cordon-Cardo C; Melamed J; Zhang Z F; Sheinfeld J; Fair W R; Herr H W; Reuter V E
Association of P53 nuclear overexpression and tumor progression in carcinoma in situ of the bladder.
The Journal of urology 1994;152(2 Pt 1):388-92.
1994: Schwalb M D; Herr H W; Sogani P C; Russo P; Sheinfeld J; Fair W R
Positive urinary cytology following a complete response to intravesical bacillus Calmette-Guerin therapy: pattern of recurrence.
The Journal of urology 1994;152(2 Pt 1):382-7.
1994: Schultz P K; Herr H W; Zhang Z F; Bajorin D F; Seidman A; Sarkis A; Fair W R; Scherr D; Bosl G J; Scher H I
Neoadjuvant chemotherapy for invasive bladder cancer: prognostic factors for survival of patients treated with M-VAC with 5-year follow-up.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(7):1394-401.
1994: Davis B E; Herr H W; Fair W R; Bosl G J
The management of patients with nonseminomatous germ cell tumors of the testis with serologic disease only after orchiectomy.
The Journal of urology 1994;152(1):111-3; discussion 114.
1994: Vieweg J; Whitmore W F; Herr H W; Sogani P C; Russo P; Sheinfeld J; Fair W R
The role of pelvic lymphadenectomy and radical cystectomy for lymph node positive bladder cancer. The Memorial Sloan-Kettering Cancer Center experience.
Cancer 1994;73(12):3020-8.
1994: Kornblith A B; Herr H W; Ofman U S; Scher H I; Holland J C
Quality of life of patients with prostate cancer and their spouses. The value of a data base in clinical care.
Cancer 1994;73(11):2791-802.
1994: Herr H W; Scher H I
Neoadjuvant chemotherapy and partial cystectomy for invasive bladder cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(5):975-80.
1994: Herr H W
Quality of life of incontinent men after radical prostatectomy.
The Journal of urology 1994;151(3):652-4.
1994: Herr H W
Urachal carcinoma: the case for extended partial cystectomy.
The Journal of urology 1994;151(2):365-6.
1994: Bosl G J; Fair W R; Herr H W; Bajorin D F; Dalbagni G; Sarkis A S; Reuter V E; Cordon-Cardo C; Sheinfeld J; Scher H I
Bladder cancer: advances in biology and treatment.
Critical reviews in oncology/hematology 1994;16(1):33-70.
1994: Herr H W
Partial nephrectomy for renal cell carcinoma with a normal opposite kidney.
Cancer 1994;73(1):160-2.
1994: Zhang Z F; Sarkis A S; Cordon-Cardo C; Dalbagni G; Melamed J; Aprikian A; Pollack D; Sheinfeld J; Herr H W; Fair W R
Tobacco smoking, occupation, and p53 nuclear overexpression in early stage bladder cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1994;3(1):19-24.
1993: Schwalb D M; Herr H W; Fair W R
The management of clinically unconfirmed positive urinary cytology.
The Journal of urology 1993;150(6):1751-6.
1993: Davis B E; Sogani P C; Herr H W
Association of primary germ cell tumor of the testis and renal cell carcinoma.
The Journal of urology 1993;150(5 Pt 1):1489-91.
1993: Bajorin D F; Sarosdy M F; Pfister D G; Mazumdar M; Motzer R J; Scher H I; Geller N L; Fair W R; Herr H; Sogani P
Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(4):598-606.
1993: Horowitz M; Herr H W; Reuter V
Untreated hypernephroma of thirty-three years.
Urology 1993;41(3):278-9.
1993: Presti J C; Herr H W; Carroll P R
Fertility and testis cancer.
The Urologic clinics of North America 1993;20(1):173-9.
1993: Herr H W; LaQuaglia M P
Management of teratoma.
The Urologic clinics of North America 1993;20(1):145-52.
1993: Herr H W; Kornblith A B; Ofman U
A comparison of the quality of life of patients with metastatic prostate cancer who received or did not receive hormonal therapy.
Cancer 1993;71(3 Suppl):1143-50.
1993: Sarkis A S; Dalbagni G; Cordon-Cardo C; Zhang Z F; Sheinfeld J; Fair W R; Herr H W; Reuter V E
Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression.
Journal of the National Cancer Institute 1993;85(1):53-9.
1993: Herr H W
A proposed simplified staging system of invasive bladder tumors.
Urologia internationalis 1993;50(1):17-20.
1992: Herr H W
Staging invasive bladder tumors.
Journal of surgical oncology 1992;51(4):217-20.
1992: Wood D P; Herr H W; Heller G; Vlamis V; Sogani P C; Motzer R J; Fair W R; Bosl G J
Distribution of retroperitoneal metastases after chemotherapy in patients with nonseminomatous germ cell tumors.
The Journal of urology 1992;148(6):1812-5; discussion 1815-6.
1992: Herr H W
Transurethral resection in regionally advanced bladder cancer.
The Urologic clinics of North America 1992;19(4):695-700.
1992: Wood D P; Herr H W; Motzer R J; Reuter V; Sogani P C; Morse M J; Bosl G J
Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers.
Cancer 1992;70(9):2354-7.
1992: Russo P; Brady M S; Conlon K; Hajdu S I; Fair W R; Herr H W; Brennan M F
Adult urological sarcoma.
The Journal of urology 1992;147(4):1032-6; discussion 1036-7.
1992: Herr H W; Wartinger D D; Fair W R; Oettgen H F
Bacillus Calmette-Guerin therapy for superficial bladder cancer: a 10-year followup.
The Journal of urology 1992;147(4):1020-3.
1992: Bajorin D F; Herr H; Motzer R J; Bosl G J
Current perspectives on the role of adjunctive surgery in combined modality treatment for patients with germ cell tumors.
Seminars in oncology 1992;19(2):148-58.
1992: Splinter T A; Scher H I; Denis L; Bukowski R; Simon S; Klimberg I; Soloway M; Vogelzang N J; van Tinteren H; Herr H
The prognostic value of the pathological response to combination chemotherapy before cystectomy in patients with invasive bladder cancer. European Organization for Research on Treatment of Cancer--Genitourinary Group.
The Journal of urology 1992;147(3):606-8.
1992: Klein E A; Rogatko A; Herr H W
Management of local bacillus Calmette-Guerin failures in superficial bladder cancer.
The Journal of urology 1992;147(3):601-5.
1992: Lamm D L; van der Meijden P M; Morales A; Brosman S A; Catalona W J; Herr H W; Soloway M S; Steg A; Debruyne F M
Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer.
The Journal of urology 1992;147(3):596-600.
1992: Herr H W
Intravesical therapy.
Hematology/oncology clinics of North America 1992;6(1):117-27.
1992: Motzer R J; Gulati S C; Crown J P; Weisen S; Doherty M; Herr H; Fair W; Sheinfeld J; Sogani P; Russo P
High-dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors. Early intervention is better tolerated.
Cancer 1992;69(2):550-6.
1992: Herr H W; Scher H I
Neoadjuvant chemotherapy and partial cystectomy for invasive bladder cancer.
Cancer treatment and research 1992;59():99-103.
1992: Sheinfeld J; Herr H W
Intervention strategies for chemoprevention of bladder cancer.
Journal of cellular biochemistry. Supplement 1992;16I():173-4.
1992: Herr H W
Intravesical BCG: current results, natural history and implications for urothelial cancer prevention.
Journal of cellular biochemistry. Supplement 1992;16I():112-9.
1991: Herr H W
[The role of radiotherapy in locally limited prostate cancer]
Der Urologe. Ausg. A 1991;30(6):413-6.
1991: Winter H I; Bretton P R; Herr H W
Preoperative prostate-specific antigen in predicting pathologic stage and grade after radical prostatectomy.
Urology 1991;38(3):202-5.
1991: Herr H W
Transurethral resection and intravesical therapy of superficial bladder tumors.
The Urologic clinics of North America 1991;18(3):525-8.
1991: Mydlo J H; Shore N; Reuter V; Herr H W
Perirenal lipoma versus renal cell carcinoma.
Urology 1991;38(1):67-9.
1991: Mydlo J H; Shore N; Herr H W
Renal cell metastases versus liver hemangioma.
Urology 1991;37(3):257-9.
1991: Motzer R J; Geller N L; Tan C C; Herr H; Morse M; Fair W; Sheinfeld J; Sogani P; Russo P; Bosl G J
Salvage chemotherapy for patients with germ cell tumors. The Memorial Sloan-Kettering Cancer Center experience (1979-1989).
Cancer 1991;67(5):1305-10.
1991: Herr H W
Progression of stage T1 bladder tumors after intravesical bacillus Calmette-Guerin.
The Journal of urology 1991;145(1):40-3; discussion 43-4.
1991: Herr H W; Klein E A; Rogatko A
Local BCG failures in superficial bladder cancer. A multivariate analysis of risk factors influencing survival.
European urology 1991;19(2):97-100.
1991: Herr H W; Toner G C; Geller N L; Bosl G J
Patient selection for retroperitoneal lymph node dissection after chemotherapy for nonseminomatous germ cell tumors.
European urology 1991;19(1):1-5.
1991: Herr H; Jakse G
pT1 bladder cancer.
European urology 1991;20(1):1-8.
1990: Herr H W
Outpatient flexible cystoscopy and fulguration of recurrent superficial bladder tumors.
The Journal of urology 1990;144(6):1365-6.
1990: Motzer R J; Cooper K; Geller N L; Bajorin D F; Dmitrovsky E; Herr H; Morse M; Fair W; Sogani P; Russo P
The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors.
Cancer 1990;66(12):2476-81.
1990: Herr H W; Whitmore W F; Morse M J; Sogani P C; Russo P; Fair W R
Neoadjuvant chemotherapy in invasive bladder cancer: the evolving role of surgery.
The Journal of urology 1990;144(5):1083-8.
1990: Herr H W; Jakse G; Sheinfeld J
The T1 bladder tumor.
Seminars in urology 1990;8(4):254-61.
1990: La Quaglia M P; Ghavimi F; Herr H; Mandell L; Pennenberg D; Hajdu S; Exelby P R
Prognostic factors in bladder and bladder-prostate rhabdomyosarcoma.
Journal of pediatric surgery 1990;25(10):1066-72.
1990: Herr H W; Scher H I
Surgery of invasive bladder cancer: is pathologic staging necessary?
Seminars in oncology 1990;17(5):590-7.
1990: Toner G C; Panicek D M; Heelan R T; Geller N L; Lin S Y; Bajorin D; Motzer R J; Scher H I; Herr H W; Morse M J
Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(10):1683-94.
1990: Fair W R; Scher H; Herr H; Morse M; Sogani P; Bosi G; Dershaw D; Reuter V; Curley T;
Neoadjuvant chemotherapy for bladder cancer: the MSKCC experience.
Seminars in urology 1990;8(3):190-6.
1990: Badalament R A; Gluck R W; Wong G Y; Gnecco C; Kreutzer E; Herr H W; Fair W R; Galicich J H
Surgical treatment of brain metastases from renal cell carcinoma.
Urology 1990;36(2):112-7.
1990: Motzer R J; Cooper K; Geller N L; Pfister D G; Lin S Y; Bajorin D; Scher H I; Herr H; Fair W; Morse M
Carboplatin, etoposide, and bleomycin for patients with poor-risk germ cell tumors.
Cancer 1990;65(11):2465-70.
1990: Herr H W; Hennessy W T; Kantor A
Pelvic sarcoma causing gynecomastia.
The Journal of urology 1990;143(5):1008-9.
1990: Klein E A; Herr H W
Suprapubic approach for bilateral orchiectomy and placement of testicular prostheses.
The Journal of urology 1990;143(4):765-6.
1990: Bretton P R; Herr H W; Kimmel M; Whitmore W F; Laudone V; Oettgen H F; Fair W R
The response of patients with superficial bladder cancer to a second course of intravesical bacillus Calmette-Guerin.
The Journal of urology 1990;143(4):710-2; discussion 712-3.
1990: Sheinfeld J; Reuter V E; Melamed M R; Fair W R; Morse M; Sogani P C; Herr H W; Whitmore W F; Cordon-Cardo C
Enhanced bladder cancer detection with the Lewis X antigen as a marker of neoplastic transformation.
The Journal of urology 1990;143(2):285-8.
1990: Herr H W
The role of surgery in initial staging and follow up.
Progress in clinical and biological research 1990;353():35-43.
1990: Splinter T A; Scher H I; Denis L; Bukowski R; Soloway M; Vogelzang N; Klimberg I; Dalesio O; Herr H
The prognostic value of the pT-category after combination chemotherapy for patients with invasive bladder cancer who underwent cystectomy. EORTC-GU group.
Progress in clinical and biological research 1990;353():219-24.
1990: Scher H; Herr H; Sternberg C; Fair W; Bosl G; Morse M; Sogani P; Watson R; Darshaw D; Reuter V
M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) and bladder preservation.
Progress in clinical and biological research 1990;353():179-86.
1990: Herr H W
Treatment of locoregional germ cell tumor.
Progress in clinical and biological research 1990;350():295-9.
1989: Sternberg C N; Yagoda A; Scher H I; Watson R C; Geller N; Herr H W; Morse M J; Sogani P C; Vaughan E D; Bander N
Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse.
Cancer 1989;64(12):2448-58.
1989: Orihuela E; Herr H W; Whitmore W F
Conservative treatment of superficial transitional cell carcinoma of prostatic urethra with intravesical BCG.
Urology 1989;34(5):231-7.
1989: Scher H; Herr H; Sternberg C; Fair W; Bosl G; Morse M; Sogani P; Watson R; Dershaw D; Reuter V
Neo-adjuvant chemotherapy for invasive bladder cancer. Experience with the M-VAC regimen.
British journal of urology 1989;64(3):250-6.
1989: LaQuaglia M P; Ghavimi F; Heller G; Herr H; Mandell L R; Corbally M; Hajdu S; Exelby P
Mortality in pediatric paratesticular rhabdomyosarcoma: a multivariate analysis.
The Journal of urology 1989;142(2 Pt 2):473-8; discussion 489.
1989: Wood D P; Herr H W
The evolving role of surgery in the management of renal cell carcinoma.
Seminars in urology 1989;7(3):172-80.
1989: Bretton P R; Herr H W; Kimmel M; Fair W R; Whitmore W F; Melamed M R
Flow cytometry as a predictor of response and progression in patients with superficial bladder cancer treated with bacillus Calmette-Guerin.
The Journal of urology 1989;141(6):1332-6.
1989: Bretton P R; Herr H W; Whitmore W F; Badalament R A; Kimmel M; Provet J; Oettgen H F; Melamed M R; Fair W R
Intravesical bacillus Calmette-Guerin therapy for in situ transitional cell carcinoma involving the prostatic urethra.
The Journal of urology 1989;141(4):853-6.
1989: Herr H W; Badalament R A; Amato D A; Laudone V P; Fair W R; Whitmore W F
Superficial bladder cancer treated with bacillus Calmette-Guerin: a multivariate analysis of factors affecting tumor progression.
The Journal of urology 1989;141(1):22-9.
1989: Scher H; Herr H
Is chemotherapy a new form of radical treatment in infiltrating tumor localized to the bladder?
Progress in clinical and biological research 1989;303():563-82.
1989: Herr H W
When is a cystectomy necessary in carcinoma in situ?
Progress in clinical and biological research 1989;303():511-5.
1989: Herr H W
BCG therapy of superficial bladder tumors.
Progress in clinical and biological research 1989;303():369-74.
1989: Herr H W
Neoadjuvant chemotherapy for invasive bladder cancer.
Seminars in surgical oncology 1989;5(4):266-71.
1988: Herr H W; Laudone V P; Badalament R A; Oettgen H F; Sogani P C; Freedman B D; Melamed M R; Whitmore W F
Bacillus Calmette-Guérin therapy alters the progression of superficial bladder cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(9):1450-5.
1988: Herr H W
Bladder cancer: pelvic lymphadenectomy revisited.
Journal of surgical oncology 1988;37(4):242-5.
1988: Herr H W; Huffman J L; Huryk R; Heston W D; Melamed M R; Whitmore W F
Anticarcinoma activity of rhodamine 123 against a murine renal adenocarcinoma.
Cancer research 1988;48(8):2061-3.
1988: Motzer R J; Bosl G J; Geller N L; Penenberg D; Yagoda A; Golbey R; Whitmore W F; Fair W R; Sogani P; Herr H
Advanced seminoma: the role of chemotherapy and adjunctive surgery.
Annals of internal medicine 1988;108(4):513-8.
1988: Scher H I; Yagoda A; Herr H W; Sternberg C N; Morse M J; Sogani P C; Watson R C; Reuter V; Whitmore W F; Fair W R
Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for extravesical urinary tract tumors.
The Journal of urology 1988;139(3):475-7.
1988: Scher H I; Yagoda A; Herr H W; Sternberg C N; Bosl G; Morse M J; Sogani P C; Watson R C; Dershaw D D; Reuter V
Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) effect on the primary bladder lesion.
The Journal of urology 1988;139(3):470-4.
1988: Sternberg C N; Yagoda A; Scher H I; Watson R C; Herr H W; Morse M J; Sogani P C; Vaughan E D; Bander N; Weiselberg L R
M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium.
The Journal of urology 1988;139(3):461-9.
1988: Sternberg C N; Yagoda A; Scher H I; Whitmore W F; Herr H W; Morse M J; Sogani P C; Bosl G; Watson R C; Hollander P S
Neo-adjuvant M-VAC chemotherapy trials in transitional cell carcinoma: perspectives for first line chemotherapy.
Progress in clinical and biological research 1988;260():551-5.
1988: Sternberg C N; Yagoda A; Scher H I; Whitmore W F; Herr H W; Morse M J; Sogani P C; Watson R C; Hollander P S; Fair W R
M-VAC: methotrexate (MTX), vinblastine (VLB), adriamycin (ADM), and cisplatin (DDP) for metastatic and node positive carcinoma of the urothelium.
Progress in clinical and biological research 1988;260():481-5.
1988: Herr H W
Chemotherapy and cystectomy in patients with bladder carcinoma.
European urology 1988;14 Suppl 1():41.
1988: Sternberg C N; Yagoda A; Scher H I; Watson R C; Herr H W; Morse M J; Sogani P C; Vaughan E D; Bander N; Geller N
Chemotherapeutic management of invasive bladder carcinoma.
European urology 1988;14 Suppl 1():19-20.
1987: Herr H W; Laudone V P; Whitmore W F
An overview of intravesical therapy for superficial bladder tumors.
The Journal of urology 1987;138(6):1363-8.
1987: Herr H W
Conservative management of muscle-infiltrating bladder cancer: prospective experience.
The Journal of urology 1987;138(5):1162-3.
1987: Russo P; Liguori G; Heston W D; Huryk R; Yang C R; Fair W R; Whitmore W F; Herr H W
Effects of intermittent diethylstilbestrol diphosphate administration on the R3327 rat prostatic carcinoma.
Cancer research 1987;47(22):5967-70.
1987: Badalament R A; Gay H; Cibas E S; Herr H W; Whitmore W F; Fair W R; Melamed M R
Monitoring intravesical bacillus Calmette-Guerin treatment of superficial bladder carcinoma by postoperative urinary cytology.
The Journal of urology 1987;138(4):763-5.
1987: Badalament R A; Gay H; Cibas E S; Herr H W; Whitmore W F; Fair W R; Melamed M R
Monitoring endoscopic treatment of superficial bladder carcinoma by postoperative urinary cytology.
The Journal of urology 1987;138(4):760-2.
1987: Badalament R A; Hermansen D K; Kimmel M; Gay H; Herr H W; Fair W R; Whitmore W F; Melamed M R
The sensitivity of bladder wash flow cytometry, bladder wash cytology, and voided cytology in the detection of bladder carcinoma.
Cancer 1987;60(7):1423-7.
1987: Orihuela E; Varadachay S; Herr H W; Melamed M R; Whitmore W F
The practical use of tumor marker determination in bladder washing specimens. Assessing the urothelium of patients with superficial bladder cancer.
Cancer 1987;60(5):1009-16.
1987: Herr H W
Quality of life measurement in testicular cancer patients.
Cancer 1987;60(6):1412-4.
1987: Herr H W
Re: Two courses of intravesical bacillus Calmette-Guerin for transitional cell carcinoma of the bladder.
The Journal of urology 1987;138(2):409-10.
1987: Herr H W; Whitmore W F
Ureteral carcinoma in situ after successful intravesical therapy for superficial bladder tumors: incidence, possible pathogenesis and management.
The Journal of urology 1987;138(2):292-4.
1987: Orihuela E; Herr H W; Pinsky C M; Whitmore W F
Toxicity of intravesical BCG and its management in patients with superficial bladder tumors.
Cancer 1987;60(3):326-33.
1987: Herr H W
Strategies for the management of recurrent and advanced urologic cancers. Quality of life.
Cancer 1987;60(3 Suppl):623-30.
1987: Carroll P R; Morse M J; Whitmore W F; Sogani P C; Klotz L; Herr H W; Fair W R; Feldshuh R; Chaganti R S
Fertility status of patients with clinical stage I testis tumors on a surveillance protocol.
The Journal of urology 1987;138(1):70-2.
1987: Motzer R; Bosl G; Heelan R; Fair W; Whitmore W; Sogani P; Herr H; Morse M
Residual mass: an indication for further therapy in patients with advanced seminoma following systemic chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(7):1064-70.
1987: Carroll P R; Whitmore W F; Richardson M; Bajorunas D; Herr H W; Williams R D; Fair W R; Chaganti R S
Testicular failure in patients with extragonadal germ cell tumors.
Cancer 1987;60(1):108-13.
1987: Badalament R A; Kimmel M; Gay H; Cibas E S; Whitmore W F; Herr H W; Fair W R; Melamed M R
The sensitivity of flow cytometry compared with conventional cytology in the detection of superficial bladder carcinoma.
Cancer 1987;59(12):2078-85.
1987: Herr H W; Bosl G
Residual mass after chemotherapy for seminoma: changing concepts of management.
The Journal of urology 1987;137(6):1234-5.
1987: Srinivas V; Morse M J; Herr H W; Sogani P C; Whitmore W F
Penile cancer: relation of extent of nodal metastasis to survival.
The Journal of urology 1987;137(5):880-2.
1987: Herr H W
Intravesical therapy. A critical review.
The Urologic clinics of North America 1987;14(2):399-404.
1987: Badalament R A; Herr H W; Wong G Y; Gnecco C; Pinsky C M; Whitmore W F; Fair W R; Oettgen H F
A prospective randomized trial of maintenance versus nonmaintenance intravesical bacillus Calmette-Guérin therapy of superficial bladder cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(3):441-9.
1987: Carroll P R; Whitmore W F; Herr H W; Morse M J; Sogani P C; Bajorunas D; Fair W R; Chaganti R S
Endocrine and exocrine profiles of men with testicular tumors before orchiectomy.
The Journal of urology 1987;137(3):420-3.
1987: Bosl G J; Geller N L; Vogelzang N J; Carey R; Auman J; Whitmore W F; Herr H; Morse M; Sogani P; Chan E
Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(3):436-40.
1987: Whitmore W F; Hilaris B; Sogani P; Herr H; Batata M; Fair W
Interstitial irradiation using I-125 seeds.
Progress in clinical and biological research 1987;243B():177-95.
1986: Badalament R A; Gay H; Whitmore W F; Herr H W; Fair W R; Oettgen H F; Melamed M R
Monitoring intravesical bacillus Calmette-Guerin treatment of superficial bladder carcinoma by serial flow cytometry.
Cancer 1986;58(12):2751-7.
1986: Herr H W; Warrel R P; Burchenal J H
Phase I trial of alpha-difluoromethyl ornithine (DFMO) and methylglyoxal bis (guanylhydrazone) (MGBG) in patients with advanced prostatic cancer.
Urology 1986;28(6):508-11.
1986: Klotz L H; Herr H W; Morse M J; Whitmore W F
Intermittent endocrine therapy for advanced prostate cancer.
Cancer 1986;58(11):2546-50.
1986: Bosl G J; Gluckman R; Geller N L; Golbey R B; Whitmore W F; Herr H; Sogani P; Morse M; Martini N; Bains M
VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(10):1493-9.
1986: Stephenson R A; Herr H W
Flow cytometry in urologic oncology.
The Urologic clinics of North America 1986;13(3):525-30.
1986: Klotz L H; Herr H W
Hodgkin's disease of the prostate: a detailed case report.
The Journal of urology 1986;135(6):1261-2.
1986: Herr H W; Whitmore W F; Sogani P C; Watson R C; Fair W R
Selection of testicular tumor patients for omission of retroperitoneal lymph node dissection.
The Journal of urology 1986;135(3):500-3.
1986: Tiffany P; Morse M J; Bosl G; Vaughan E D; Sogani P C; Herr H W; Whitmore W F
Sequential excision of residual thoracic and retroperitoneal masses after chemotherapy for stage III germ cell tumors.
Cancer 1986;57(5):978-83.
1986: Herr H W; Pinsky C M; Whitmore W F; Sogani P C; Oettgen H F; Melamed M R
Long-term effect of intravesical bacillus Calmette-Guerin on flat carcinoma in situ of the bladder.
The Journal of urology 1986;135(2):265-7.
1986: Yoshida O; Bono A; Braeckman J; Herr H; Jauhiainen K; Matsumura Y; Oosterlinck W; Ueda T; Bollack C
Clinical follow-up.
Progress in clinical and biological research 1986;221():287-93.
1986: Soloway M S; Kurth K H; Herr H; Huland H; Denis L; Suzuki K; Blandy J; Hisazumi H; Koontz W; Tsugawa R
Surgical techniques in the management of patients with superficial bladder cancer.
Progress in clinical and biological research 1986;221():123-32.
1986: Raghavan D; Debruyne F; Herr H; Jocham D; Kakizoe T; Okajima E; Sandberg A; Tannock I
Experimental models of bladder cancer: a critical review.
Progress in clinical and biological research 1986;221():171-208.
1985: Berger Y; Srinivas V; Hajdu S I; Herr H W
Epidermoid cysts of the testis: role of conservative surgery.
The Journal of urology 1985;134(5):962-3.
1985: Huffman J L; Morse M J; Herr H W; Whitmore W F
Consideration for treatment of upper urinary tract tumors with topical therapy.
Urology 1985;26(4 Suppl):47-50.
1985: Huffman J L; Fradet Y; Cordon-Cardo C; Herr H W; Pinsky C M; Oettgen H F; Old L J; Whitmore W F; Melamed M R
Effect of intravesical Bacillus Calmette-Guérin on detection of a urothelial differentiation antigen in exfoliated cells of carcinoma in situ of the human urinary bladder.
Cancer research 1985;45(10):5201-4.
1985: Herr H W
Durable response of a carcinoma in situ of the renal pelvis to topical bacillus Calmette-Guerin.
The Journal of urology 1985;134(3):531-2.
1985: Staiano-Coico L; Huffman J; Wolf R; Pinsky C M; Herr H W; Whitmore W F; Oettgen H F; Darzynkiewicz Z; Melamed M R
Monitoring intravesical bacillus Calmette-Guerin treatment of bladder carcinoma with flow cytometry.
The Journal of urology 1985;133(5):786-8.
1985: Klein F A; Herr H W
Case profile: Crossed fused ectopia misdiagnosed as retroperitoneal tumor.
Urology 1985;25(4):411-2.
1985: Sternberg C N; Yagoda A; Scher H I; Watson R C; Ahmed T; Weiselberg L R; Geller N; Hollander P S; Herr H W; Sogani P C
Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium.
The Journal of urology 1985;133(3):403-7.
1985: Huffman J L; Bagley D H; Lyon E S; Morse M J; Herr H W; Whitmore W F
Endoscopic diagnosis and treatment of upper-tract urothelial tumors. A preliminary report.
Cancer 1985;55(6):1422-8.
1985: Bosl G J; Yagoda A; Golbey R B; Whitmore W; Herr H; Sogani P; Morse M; Vogelzang N; MacDonald G
Role of etoposide-based chemotherapy in the treatment of patients with refractory or relapsing germ cell tumors.
The American journal of medicine 1985;78(3):423-8.
1985: Stanton G F; Bosl G J; Whitmore W F; Herr H; Sogani P; Morse M; Golbey R B
VAB-6 as initial treatment of patients with advanced seminoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1985;3(3):336-9.
1985: Srinivas V; Herr H W; Hajdu E O
Partial nephrectomy for a renal oncocytoma associated with tuberous sclerosis.
The Journal of urology 1985;133(2):263-5.
1985: Herr H W
Preoperative irradiation with and without chemotherapy as adjunct to radical cystectomy.
Urology 1985;25(2):127-34.
1985: Herr H W; Pinsky C M; Whitmore W F; Sogani P G; Oettgen H F; Melamed M R
Experience with intravesical bacillus Calmette-Guèrin therapy of superficial bladder tumors.
Urology 1985;25(2):119-23.
1985: Whitmore W F; Hilaris B; Batata M; Sogani P; Herr H; Morse M
Interstitial radiation: short-term palliation or curative therapy?
Urology 1985;25(2 Suppl):24-9.
1984: Herr H W; Kleinert E L; Conti P S; Burchenal J H; Whitmore W F
Effects of alpha-difluoromethylornithine and methylglyoxal bis(guanylhydrazone) on the growth of experimental renal adenocarcinoma in mice.
Cancer research 1984;44(10):4382-5.
1984: Ghavimi F; Herr H; Jereb B; Exelby P R
Treatment of genitourinary rhabdomyosarcoma in children.
The Journal of urology 1984;132(2):313-9.
1984: Ahmed T; Benedetto P; Yagoda A; Watson R C; Scher H I; Herr H W; Sogani P C; Whitmore W F; Pertschuk L
Estrogen, progesterone, and androgen-binding sites in renal cell carcinoma. Observations obtained in Phase II trial of flutamide.
Cancer 1984;54(3):477-81.
1984: Bosl G J; Yagoda A; Whitmore W F; Sogani P; Herr H; Vugrin D; Dukeman M; Golbey R
VP-16-213 and cisplatin in the treatment of patients with refractory germ cell tumors.
American journal of clinical oncology 1984;7(4):327-30.
1984: Sogani P C; Whitmore W F; Herr H W; Bosl G J; Golbey R B; Watson R C; DeCosse J J
Orchiectomy alone in the treatment of clinical stage I nonseminomatous germ cell tumor of the testis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1984;2(4):267-70.
1984: Klein F A; Whitmore W F; Sogani P C; Batata M; Fisher H; Herr H W
Inguinal lymph node metastases from germ cell testicular tumors.
The Journal of urology 1984;131(3):497-500.
1984: Herr H W; Kleinert E L; Relyea N M; Whitmore W F
Potentiation of methylglyoxal-bis-guanylhydrazone by alpha-difluoromethylornithine in rat prostate cancer.
Cancer 1984;53(6):1294-8.
1984: Herr H W
Major surgery and scleromyxedema.
The New England journal of medicine 1984;310(12):788-9.
1984: Herr H W; Kleinert E L
Antigrowth effect of polyamine biosynthesis inhibitors on the Dunning R 3327-G prostatic tumor.
The Prostate 1984;5(4):439-44.
1984: Herr H W
Immunotherapy of bladder tumors.
Uremia investigation 1984;8(3-4):257-61.
1983: Herr H W; Yagoda A; Batata M; Sogani P C; Whitmore W F
Planned preoperative cisplatin and radiation therapy for locally advanced bladder cancer.
Cancer 1983;52(12):2205-8.
1983: Sogani P C; Herr H W; Bains M S; Whitmore W F
Renal cell carcinoma extending into inferior vena cava.
The Journal of urology 1983;130(4):660-3.
1983: Herr H W
Interstitial irradiation for localized prostate cancer.
Seminars in urology 1983;1(3):222-8.
1983: Klein F A; Herr H W; Vugrin D
Fibrosarcoma associated with intensive chemotherapy for advanced germ cell testicular tumor.
Journal of surgical oncology 1983;23(1):5-7.
1983: Smith J A; Herr H W; Middleton R G
Bladder carcinosarcoma: histologic variation in metastatic lesions.
The Journal of urology 1983;129(4):829-31.
1983: Klein F A; Whitmore W F; Herr H W; Morse M J; Sogani P C
Inferior pubic rami resection with en bloc radical excision for invasive proximal urethral carcinoma.
Cancer 1983;51(7):1238-42.
1983: Klein F A; Whitmore W F; Wolf R M; Herr H W; Sogani P C; Staiano-Coico L; Melamed M R
Presumptive downstaging from preoperative irradiation for bladder cancer as determined by flow cytometry: preliminary report.
International journal of radiation oncology, biology, physics 1983;9(4):487-91.
1983: Herr H W; Pinsky C M; Whitmore W F; Oettgen H F; Melamed M R
Effect of intravesical Bacillus Calmette-Guerin (BCG) on carcinoma in situ of the bladder.
Cancer 1983;51(7):1323-6.
1983: Herr H W
Carcinoma in situ of the bladder.
Seminars in urology 1983;1(1):15-22.
1983: Herr H W
Association of depressed mixed lymphocyte reactivity with the development of bladder carcinoma in patients with papillomas.
Cancer 1983;51(2):344-7.
1983: Klein F A; Herr H W; Sogani P C; Whitmore W F
Panniculectomy in conjunction with radical cystectomy in the obese patient.
Surgery, gynecology & obstetrics 1983;156(1):31-3.
1983: Vugrin D; Whitmore W F; Herr H W; Sogani P; Golbey R B
VAB-6 combination chemotherapy in resected stage II-B testis cancer.
Cancer 1983;51(1):5-8.
1983: Herr H W
The patient, disease status, and treatment options for prostate cancer: stages B1 and B2.
The Prostate 1983;4(5):447-59.
1982: Vugrin D; Whitmore W F; Herr H; Sogani P; Golbey R B
Adjuvant vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum chemotherapy regimen with and without maintenance in patients with resected stage IIB testis cancer.
The Journal of urology 1982;128(4):715-7.
1982: Klein F A; Herr H W; Whitmore W F; Sogani P C; Melamed M R
An evaluation of automated flow cytometry (FCM) in detection of carcinoma in situ of the urinary bladder.
Cancer 1982;50(5):1003-8.
1982: Klein F A; Herr H W; Sogani P C; Whitmore W F; Melamed M R
Detection and follow-up of carcinoma of the urinary bladder by flow cytometry.
Cancer 1982;50(3):389-95.
1982: Klein F A; Whitmore W F; Herr H W; Melamed M R
Flow cytometry followup of patients with low stage bladder tumors.
The Journal of urology 1982;128(1):88-92.
1982: Pollack M S; Vugrin D; Hennessy W; Herr H W; Dupont B; Whitmore W F
HLA antigens in patients with germ cell cancers of the testis.
Cancer research 1982;42(6):2470-3.
1982: Klein F A; Herr H W; Sogani P C; Whitmore W F; Melamed M R
Flow cytometry of normal and nonneoplastic diseases of the bladder: an estimate of the false positive rate.
The Journal of urology 1982;127(5):946-8.
1982: Tertzakian G M; Herr H W; Mehta M B
Orbital metastases from prostatic carcinoma.
Urology 1982;19(4):427-9.
1982: Herr H W
Cyclophosphamide, methotrexate and 5-fluorouracil combination chemotherapy versus chloroethyl-cyclohexy-nitrosourea in the treatment of metastatic prostatic cancer.
The Journal of urology 1982;127(3):462-5.
1982: Pertschuk L P; Rosenthal H E; Macchia R J; Eisenberg K B; Feldman J G; Wax S H; Kim D S; Whitmore W F; Abrahams J I; Gaetjens E; Wise G J; Herr H W; Karr J P; Murphy G P; Sandberg A A
Correlation of histochemical and biochemical analyses of androgen binding in prostatic cancer: relation to therapeutic response.
Cancer 1982;49(5):984-93.
1982: Smith J A; Batata M; Grabstald H; Sogani P C; Herr H; Whitmore W F
Preoperative irradiation and cystectomy for bladder cancer.
Cancer 1982;49(5):869-73.
1982: Klein F A; Melamed M R; Whitmore W F; Herr H W; Sogani P C; Darzynkiewicz Z
Characterization of bladder papilloma by two-parameter DNA-RNA flow cytometry.
Cancer research 1982;42(3):1094-7.
1982: Garcias V A; Herr H W
Henoch-Schönlein purpura associated with cancer of prostate.
Urology 1982;19(2):155-8.
1982: Herr H W; Whitmore W F
Significance of prostatic biopsies after radiation therapy for carcinoma of the prostate.
The Prostate 1982;3(4):339-50.
1982: Grossman H B; Kleinert E L; Herr H W; Whitmore W F
Effects of estrogen administration on serum testosterone in Copenhagen rats.
The Prostate 1982;3(3):225-9.
1982: Herr H W
Effect of estrogen on the mixed lymphocyte reaction in normal individuals and prostatic cancer patients.
The Prostate 1982;3(1):17-21.
1981: Lynch D F; Herr H W
Radiation-induced sarcoma following radiotherapy for testicular tumor.
The Journal of urology 1981;126(6):845-6.
1981: Herr H W
Adherent suppressor cells in the blood of patients with bladder cancer.
The Journal of urology 1981;126(4):457-60.
1981: Engen D E; Herr H W
Conservative management of renal adenoma v. adenocarcinoma.
British journal of urology 1981;53(4):387.
1981: Vugrin D; Herr H W; Whitmore W F; Sogani P C; Golbey R B
VAB-6 combination chemotherapy in disseminated cancer of the testis.
Annals of internal medicine 1981;95(1):59-61.
1981: Vugrin D; Whitmore W F; Sogani P C; Bains M; Herr H W; Golbey R B
Combined chemotherapy and surgery in treatment of advanced germ-cell tumors.
Cancer 1981;47(9):2228-31.
1981: Klein F A; Herr H W; Whitmore W F; Pinsky C H; Oettgen H T; Melamed M R
Automated flow cytometry to monitor intravesical BCG therapy of superficial bladder cancer.
Urology 1981;17(4):310-4.
1981: Grossman H B; Kleinert E L; Lesser M L; Herr H W; Whitmore W F
Androgen stimulated chemotherapy in the Dunning R-3327 prostatic adenocarcinoma.
Urological research 1981;9(5):237-40.
1981: Herr H W; Kleinert E L; Whitmore W F
Mercury-induced necrosis of murine renal cell carcinoma.
Journal of surgical oncology 1981;18(1):95-9.
1980: Herr H W
Iodine-125 implantation in the management of localized prostatic carcinoma.
The Urologic clinics of North America 1980;7(3):605-13.
1980: Smith J A; Herr H W
Spontaneous regression of pulmonary metastases from transitional cell carcinoma.
Cancer 1980;46(6):1499-502.
1980: Herr H W
Cis-diamminedichloride platinum II in the treatment of advanced bladder cancer.
The Journal of urology 1980;123(6):853-5.
1980: Herr H W
Effect of irradiation on the immunocompetence of peripheral blood and regional lymph node lymphocytes in bladder cancer.
The Journal of surgical research 1980;28(6):497-500.
1980: Herr H W
Suppressor cells in immunodepressed bladder and prostate cancer patients.
The Journal of urology 1980;123(5):635-9.
1980: Tertzakian G M; Herr H W
Ganglioneuroma arising in accessory adrenal gland.
Urology 1980;15(4):401-4.
1980: Green R; Herr H W; Martin D C
Urethral stricture disease: experience with patch graft urethroplasty.
Military medicine 1980;145(2):126-8.
1979: Hadley D; Herr H W
Peripheral neuropathy associated with cis-dichlorodiammineplatinum (II) treatment.
Cancer 1979;44(6):2026-8.
1979: Herr H W; Wheeler M R
A new caliper: uses in surgery.
American journal of surgery 1979;138(5):742-3.
1979: Engen D E; Herr H W
Hemosiderosis of urinary bladder.
Urology 1979;14(4):384-6.
1979: Herr H W
Complications of pelvic lymphadenectomy and retropubic prostatic 125I implantation.
Urology 1979;14(3):226-9.
1979: Sterzer S K; Herr H W; Mintz I
Idiopathic retroperitonial fibrosis misinterpreted as lymphoma by computed tomography.
The Journal of urology 1979;122(3):405-6.
1979: Herr H W
Sexual potency retained with 125I implantation.
Geriatrics 1979;34(7):11.
1979: Herr H W
Cleft glans penis.
The Journal of urology 1979;121(5):690.
1979: Herr H W
Preservation of sexual potency in prostatic cancer patients after pelvic lymphadenectomy and retropubic 125I implantation.
The Journal of urology 1979;121(5):621-3.
1979: Herr H W; Engen D E; Hostetler J
Malignancy in uremia: dialysis versus transplantation.
The Journal of urology 1979;121(5):584-6.
1979: Herr H W
Preservation of sexual potency in prostatic cancer patients after 125I implantation.
Journal of the American Geriatrics Society 1979;27(1):17-9.
1979: Hadley D A; Herr H W; Wuerker R B
Evaluation of postirradiated prostate biopsy for prostatic carcinoma.
Surgical forum 1979;30():572-4.
1979: Herr H W
Suppressor cells in the pelvic lymph nodes regional to bladder cancer.
Journal of surgical oncology 1979;11(4):289-93.
1978: Bean M A; Miller R A; Kodera Y; Herr H W
Function of cryopreserved human effector cells in antibody-dependent, cell-mediated cytotoxicity.
National Cancer Institute monograph 1978;(49):93-5.
1978: Herr H W; Kemeny N; Yagoda A; Whitmore W F
Poly I:C immunotherapy in patients with papillomas or superficial carcinomas of the bladder.
National Cancer Institute monograph 1978;(49):325.
1978: Herr H W; Bean M A; Whitmore W F
Mixed leukocyte culture reactivity of lymph node cells regional to transitional cell carcinoma of the bladder.
National Cancer Institute monograph 1978;(49):177-81.
1978: Bean M A; Schellhammer P S; Herr H W; Pinsky C M; Whitmore W F
Immunocompetence of patients with transitional cell carcinoma as measured by dinitrochlorobenzene skin tests and in vitro lymphocyte function.
National Cancer Institute monograph 1978;(49):111-4.
1978: Wheeler M R; Herr H W
Use of a caliper to determine dimensions of the volume to be implanted with 125iodine in the treatment of prostatic carcinoma.
The Journal of urology 1978;120(3):306-7.
1978: Green R; Herr H; Scott M; Cosgrove M; Schwarz H; Martin D
Cryptorchidism and testicular neoplasia.
Journal of the National Medical Association 1978;70(9):659-64.
1978: Herr H W
Immune reactivity of lymph nodes regional to prostatic cancer.
The Journal of surgical research 1978;24(5):409-14.
1978: Herr H W
Nonspecific suppressor cells in peripheral blood of patients with urologic cancers.
Surgical forum 1978;29():623-5.
1977: Herr H W; Whitmore W F; Lieberman P H; Grabstald H
Rectal invasion by benign prostatic hyperplasia.
The Journal of urology 1977;118(3):497-9.
1977: Herr H W
Immunologic reactivity of lymph nodes regional to prostatic cancer: preliminary observations.
Journal of surgical oncology 1977;9(5):509-16.
1977: Herr H W
Suppressor cell activity in lymph nodes regional to bladder carcinoma.
Surgical forum 1977;28():546-8.
1976: Herr H W; Bean M A; Whitmore W F
Decreased ability of blood leukocytes from patients with tumors of the urinary bladder to act as stimulator cells in mixed leukocyte culture.
Cancer research 1976;36(8):2754-60.
1976: Miller R A; Bean M A; Kodera Y; Herr H W
Cryopreservation of human effector cells active in antibody-dependent cell-mediated cytotoxicity.
Transplantation 1976;21(6):517-9.
1976: Herr H W; Bean M A; Whitmore W F
Prognostic significance of regional lymph node histology in cancer of the bladder.
The Journal of urology 1976;115(3):264-7.
1976: Herr H W
Immunobiology of human bladder cancer.
The Journal of urology 1976;115(2):147-9.
1975: Herr H W
Intermittent catheterization in neurogenic bladder dysfunction.
The Journal of urology 1975;113(4):477-9.
1975: Herr H W; Bean M A
Letter: "Immunostaging" patients with malignant disease.
Urology 1975;05(3):428-9.
1975: Naftel W; Ravera J; Herr H W
Pseudocyst of pancreas simulating a renal neoplasm.
Urology 1975;05(3):417-9.
1975: Herr H W; Engelman E R; Martin D C
External sphincterotomy in traumatic and non-traumatic neurogenic bladder dysfunction.
The Journal of urology 1975;113(1):34-6.
1975: Herr H W
Recent advances in the immunobiology of human bladder cancer.
Clinical bulletin 1975;5(4):149-53.
1974: Engelman E R; Herr H W; Ravera J
Lipogranulomatosis of external genitalia.
Urology 1974;3(3):358-61.
1973: Herr H W
Hydronephrosis and hydroureter major problem in patients with spinal cord injury.
Urology 1973;2(4):478-9.
1973: Herr H W; Silber I; Martin D C
Management of inguinal lymph nodes in patients with testicular tumors following orchiopexy, inguinal or scrotal operations.
The Journal of urology 1973;110(2):223-4.
1973: Herr H W; Martin D C
Primary or pseudohyperparathyroidism?
Urology 1973;2(1):62-5.
1973: Herr H W
Use of prophylactic antibiotics in the high-risk patient undergoing prostatectomy: effect on morbidity.
The Journal of urology 1973;109(4):686-8.
1973: Herr H W; Bruffy J; Serdar I; Bischoff A J
Unsuspected primary cortical renal cell carcinoma presenting as a metastatic subepithelial pelvic filling defect.
The Journal of urology 1973;109(2):177-8.
1972: Herr H W; Jepson P M; Bischoff A J
Complete vertical cleft of the glans penis.
The Journal of urology 1972;108(2):282-3.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Harry Herr

Research Profile (preview)

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Harry Herr (preview)

All Publications